Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dwi Guna Laksana Tbk. (DWGL) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Dwi Guna Laksana Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Dwi Guna Laksana Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Dwi Guna Laksana Tbk. trades at Rp356 (market cap 3.52T, 7.1M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Dwi Guna Laksana Tbk. is far larger — about 5.5× UBC Medical Indonesia Tbk.'s market cap, and Dwi Guna Laksana Tbk. is more actively traded (7.1M versus 843K). Which is the better fit depends on your goals.

DWGLLABS
Market Cap
3.52T635.95B
Volume
7.1M843K
Lot
71.04K8.43K
Turnover
2.62B137.6M
Average Price
368.33163.22
Value
2.62B137.6M
Indicative Equilibrium Price
356165
Indicative Equilibrium Volume
2.26K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DWGL
View details
LABS
View details

About Dwi Guna Laksana Tbk.

PT Dwi Guna Laksana Tbk (the Company) was established based on Notarial Deed No. 4 dated November 10, 1986 of Cornelia Juanda Tanuraharja, SH., a public notary in Surakarta.

Read more on DWGL

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS